Suppr超能文献

西班牙杂色卟啉症的遗传学研究。基因突变鉴定及携带者检测的家系研究。

Genetic studies in variegate porphyria in Spain. Identification of gene mutations and family study for carrier detection.

作者信息

Lecha M, Badenas C, Puig S, Orfila J, Milà M, To-Figueras J, Muñoz C, Mercader P, Herrero C

机构信息

Department of Dermatology, Facultat de Medicina, Universitat de Barcelona, Spain.

出版信息

J Eur Acad Dermatol Venereol. 2006 Sep;20(8):974-9. doi: 10.1111/j.1468-3083.2006.01705.x.

Abstract

BACKGROUND

First, to establish the mutations of the protoporphyrinogen-oxidase (PPOX) gene in four Spanish patients with variegate porphyria (VP). Second, study of carrier status detection in the families, including a four-generation Balearic family. Third, evaluation of the results of carrier detection screening methods.

DESIGN

Blood samples of four patients and of 139 members belonging to four families, including four generations of a Balearic family were processed for mutation analysis of the 13 exons of PPOX gene. Biochemical studies were performed together (blood and faecal porphyrin analysis) and plasma fluorescence scanning for 626 nm peak emission detection. A questionnaire regarding clinical manifestations was submitted to all family members studied.

RESULTS

Single strand conformational analysis (SSCP) of DNA allowed the detection of the following mutations: W224R, 746delT: exon 7, 1077-1082insC: exon 10, and IVS6+2T-->A. Mutation was present in 19 of the 139 members of the families studied. Clinical manifestations or biochemical alterations were checked in the carriers detected and found as not relevant or not present. Only 11 members of the 19 mutation-bearing individuals showed plasma fluorescence PV peak positivity.

CONCLUSION

Demonstration of gene mutation is the most reliable means of detecting carriers in studies of variegate porphyria families. DNA analysis is the most sensitive carrier detection method and also allows transmission behaviour of the genetic defect to be established in successive generations of the affected families.

摘要

背景

第一,确定四名西班牙混合型卟啉病(VP)患者的原卟啉原氧化酶(PPOX)基因突变。第二,研究这些家庭中携带者状态的检测情况,包括一个来自巴利阿里群岛的四代家庭。第三,评估携带者检测筛查方法的结果。

设计

对四名患者以及来自四个家庭(包括一个巴利阿里群岛家庭的四代成员)的139名成员的血液样本进行PPOX基因13个外显子的突变分析。同时进行生化研究(血液和粪便卟啉分析)以及血浆荧光扫描以检测626nm峰值发射。向所有接受研究的家庭成员发放了一份关于临床表现的问卷。

结果

DNA的单链构象分析(SSCP)检测到以下突变:W224R、746delT(外显子7)、1077 - 1082insC(外显子10)以及IVS6 + 2T→A。在所研究的139名家庭成员中,有19人存在突变。对检测到的携带者进行了临床表现或生化改变的检查,发现这些表现不相关或不存在。在19名携带突变的个体中,只有11人血浆荧光PV峰值呈阳性。

结论

在混合型卟啉病家族研究中,基因突变的检测是检测携带者最可靠的方法。DNA分析是最敏感的携带者检测方法,还能确定受影响家族连续几代中遗传缺陷的传递情况。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验